A New Dawn in Cannabinoid Medicine
At Alterola, our aim is to provide better medicines for patients across the globe.
We believe in harnessing the therapeutic potential of cannabinoids and cannabinoid- like compounds,
which can bring valuable treatments to seriously ill patients.
Rather than just focussing on one method of identifying, researching and developing such medicines, we
are interested in developing new medicines from all sources including botanical, traditional chemical
synthesis and biosynthetic methodologies.
At ABTI Pharma we started a journey of uncovering molecules which help address patients’ unmet medical needs by developing better treatments for conditions encountered by patients across the globe.
This journey will continue as ABTI Pharma Limited becomes part of the Alterola Biotech Group.
UNMET MEDICAL NEEDS
TREATMENTS THROUGH INNOVATION
At Alterola, our background and experience enables us to utilize multiple technologies to develop our product pipeline.
This will enable us to:
- Develop new IP-protected molecules
- Aim to reduce Cost of Goods (CoGs)
- Improve Drug Delivery